Filing Details
- Accession Number:
- 0000950170-24-129384
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-20 17:00:16
- Reporting Period:
- 2024-11-18
- Accepted Time:
- 2024-11-20 17:00:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1556263 | Syros Pharmaceuticals Inc. | SYRS | Pharmaceutical Preparations (2834) | 453772460 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1865490 | Kristin Stephens | C/O Syros Pharmaceuticals, Inc. 35 Cambridgepark Drive Cambridge MA 02140 | Chief Development Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-11-18 | 36,133 | $0.22 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
